CFRX insider filings
CONTRAFECT Corp — 23 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-02-16. Screen CFRX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for CFRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — CONTRAFECT Corp
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-02-16 | 4 | Messinger Michael — Chief Financial Officer | Grant/award (A): 25,000 (derivative) @ $5.04 | EDGAR |
| 2022-05-18 | 4 | Barlow Jane F — Director | Grant/award (A): 42,000 (derivative) @ $3.35 | EDGAR |
| 2022-05-18 | 4 | Sucoff Cary — Director | Grant/award (A): 42,000 (derivative) @ $3.35 | EDGAR |
| 2022-05-18 | 4 | Low David N. — Director | Grant/award (A): 42,000 (derivative) @ $3.35 | EDGAR |
| 2022-05-18 | 4 | Aklog Lishan — Director | Grant/award (A): 42,000 (derivative) @ $3.35 | EDGAR |
| 2022-05-18 | 4 | GILMAN STEVEN C — Director | Grant/award (A): 42,000 (derivative) @ $3.35 | EDGAR |
| 2022-05-18 | 4 | OTTO MICHAEL J. — Director | Grant/award (A): 42,000 (derivative) @ $3.35 | EDGAR |
| 2022-05-18 | 4 | BARER SOL J — Director | Grant/award (A): 42,000 (derivative) @ $3.35 | EDGAR |
| 2022-02-17 | 4 | Pomerantz Roger — Chief Executive Officer, Director | Grant/award (A): 500,000 (derivative) @ $3.33 | EDGAR |
| 2022-02-17 | 4 | Messinger Michael — Chief Financial Officer | Grant/award (A): 165,000 (derivative) @ $3.33 | EDGAR |
| 2022-02-17 | 4 | Cassino Cara M — Chief Medical Officer | Grant/award (A): 160,000 (derivative) @ $3.33 | EDGAR |
| 2022-02-17 | 4 | Bogdanos Natalie — General Counsel | Grant/award (A): 125,000 (derivative) @ $3.33 | EDGAR |
| 2021-05-21 | 4 | Sucoff Cary — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | Low David N. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | Aklog Lishan — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | GILMAN STEVEN C — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | OTTO MICHAEL J. — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-05-20 | 4 | BARER SOL J — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-04-14 | 4 | Messinger Michael — Chief Financial Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2021-04-13 | 4 | Cassino Cara M — Chief Medical Officer | Grant/award (A): 80,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2021-04-13 | 4 | Bogdanos Natalie — General Counsel | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2021-04-13 | 4 | Pomerantz Roger — Chief Executive Officer, Director | Grant/award (A): 254,000 (derivative) @ $0 | EDGAR |
| 2021-02-11 | 4 | Barlow Jane F — Director | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — CONTRAFECT Corp
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-12-05 | 8-K | 1.03 — Bankruptcy or Receivership 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-11-15 | 8-K | ? 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-11-08 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-09-29 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-08-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-07-25 | 8-K | 8.01 — Other Events | EDGAR |
| 2023-06-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-20 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2023-05-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CFRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs